Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

BACKGROUND: Pancreatic cancer is the fourth commonest cause of death from cancer in men and women. Advantages in surgical techniques, radiation therapy techniques, chemotherapeutic regimes, and different combined-modality approaches have yielded only a modest impact on the prognosis of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266352/
https://www.ncbi.nlm.nih.gov/pubmed/16219105
http://dx.doi.org/10.1186/1471-2407-5-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266352/
https://www.ncbi.nlm.nih.gov/pubmed/16219105
http://dx.doi.org/10.1186/1471-2407-5-131

Ejemplares similares